Ge XY - Search Results

1

An experimental study of the management of severe keratoconjunctivitis sicca with autologous reduced-sized submandibular gland transplantation.

Ge XY, Yu GY, Fu J, Wu DC, Zhang XX, Wang YX, Li SL. Ge XY, et al. Br J Oral Maxillofac Surg. 2012 Sep;50(6):562-6. doi: 10.1016/j.bjoms.2011.10.004. Epub 2011 Nov 1. Br J Oral Maxillofac Surg. 2012. PMID: 22051179

2

Long-term survival of an allografted submandibular gland in a miniature swine model given immunosuppressant drugs.

Ge XY, Yu GY, Cai ZG, Mao C. Ge XY, et al. Br J Oral Maxillofac Surg. 2006 Apr;44(2):146-51. doi: 10.1016/j.bjoms.2005.04.004. Br J Oral Maxillofac Surg. 2006. PMID: 15905005

3

Establishment of submandibular gland allotransplantation model in miniature swine.

Ge XY, Yu GY, Cai ZG, Mao C. Ge XY, et al. Chin Med J (Engl). 2006 Mar 20;119(6):482-7. Chin Med J (Engl). 2006. PMID: 16584646

4

The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo.

Xing F, Li S, Ge X, Wang C, Zeng H, Li D, Dong L. Xing F, et al. Oral Oncol. 2008 Oct;44(10):963-9. doi: 10.1016/j.oraloncology.2007.12.001. Epub 2008 Feb 20. Oral Oncol. 2008. PMID: 18282784

5

Quinacrine enhances cisplatin-induced cytotoxicity in four cancer cell lines.

Wang Y, Bi Q, Dong L, Li X, Ge X, Zhang X, Fu J, Wu D, Li S. Wang Y, et al. Chemotherapy. 2010;56(2):127-34. doi: 10.1159/000313525. Epub 2010 Apr 20. Chemotherapy. 2010. PMID: 20407239

6

Investigation of the efficacy of a bevacizumab-cetuximab-cisplatin regimen in treating head and neck squamous cell carcinoma in mice.

Wang Y, Dong L, Bi Q, Li X, Wu D, Ge X, Zhang X, Fu J, Zhang C, Wang C, Li S. Wang Y, et al. Target Oncol. 2010 Dec;5(4):237-43. doi: 10.1007/s11523-010-0164-3. Epub 2010 Nov 18. Target Oncol. 2010. PMID: 21086056

7

Beyond antiangiogenesis: intratumorally injected bevacizumab plays a cisplatin-sensitizing role in squamous cell carcinomas in mice.

Wang Y, Dong L, Bi Q, Ge X, Zhang X, Wu D, Fu J, Zhang C, Wang C, Li S. Wang Y, et al. Chemotherapy. 2011;57(3):244-52. doi: 10.1159/000326485. Epub 2011 May 19. Chemotherapy. 2011. PMID: 21597289

8

Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.

Dong L, Ge XY, Wang YX, Yang LQ, Li SL, Yu GY, Gao Y, Fu J. Dong L, et al. Among authors: ge xy. Oral Oncol. 2013 Nov;49(11):1051-8. doi: 10.1016/j.oraloncology.2013.07.012. Epub 2013 Aug 17. Oral Oncol. 2013. PMID: 23962790

9

Reactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83.

Ge XY, Yang LQ, Jiang Y, Yang WW, Fu J, Li SL. Ge XY, et al. PLoS One. 2014 Jun 25;9(6):e101207. doi: 10.1371/journal.pone.0101207. eCollection 2014. PLoS One. 2014. PMID: 24963720 Free PMC article.

10

Nimotuzumab suppresses epithelial-mesenchymal transition and enhances apoptosis in low-dose UV-C treated salivary adenoid cystic carcinoma cell lines in vitro.

Jiang Y, Ge XY, Liu SM, Zheng L, Huang MW, Shi Y, Fu J, Zhang JG, Li SL. Jiang Y, et al. Among authors: ge xy. Anticancer Drugs. 2014 Oct;25(9):1052-60. doi: 10.1097/CAD.0000000000000139. Anticancer Drugs. 2014. PMID: 25035960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters